3D Printed Custom Applicators for HDR BT (DISCO)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRoyal North Shore Hospital
About this trial
Intracavitary brachytherapy for gynaecological cancer currently use cylinder-type applicators or custom wax moulds to place a radioactive source in close proximity to the treatment area and provide highly conformal dose distributions. This study is a Phase IIa non-randomised interventional pilot trial that will investigate the feasibility of successfully treating patients with 3D-printed custom applicators.
Eligibility criteria
Qualifiers
Able to give informed consent
Patients indicated for intracavitary brachytherapy
FIGO stage I-IVA
ECOG 0-2
Disqualifiers
Pregnancy
Patients contraindicated for brachytherapy
Inflammatory bowel disease/history of adhesions/bowel obstruction
Renal transplant/horseshoe kidney
Trial design
Treatments tested in this trial
- 3D-printed custom applicator
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
1Royal North Shore Hospital2067, St LeonardsNew South Wales, Australia
Sponsors and collaborators
Royal North Shore Hospital
Lead sponsor
Northern Sydney and Central Coast Area Health Service
Collaborator
Source ClinicalTrials.gov